Literature DB >> 24756058

Neuroprotective effect of N-acetyl cysteine against streptozotocin-induced memory dysfunction and oxidative damage in rats.

Atish Prakash, Jaspreet Kaur Kalra, Anil Kumar.   

Abstract

BACKGROUND: Growing evidences indicate that endogenous oxidants and antioxidant defense interact in a vicious cycle, which plays a critical role in the pathogenesis of cognitive dysfunction. In this study, we examined the effect of N-acetyl cysteine (NAC) against the intracerebroventricular infusion of streptozotocin (ICV STZ)-induced cognitive impairment and mitochondrial oxidative damage in rats.
METHODS: Male adult Wistar rats were injected with STZ (3 mg/kg) bilaterally through ICV. NAC (50 and 100 mg/kg) was administered for 3 weeks post-surgery. The rats were sacrificed on the 21st day following the last behavioral test, and cytoplasmic fractions of the hippocampus and cortex were prepared for the quantification of acetylcholinesterase, oxidative stress parameter, mitochondrial enzymes, inflammatory mediators and caspase-3 activity.
RESULTS: ICV STZ resulted in poor retention of memory in Morris water maze. It also increased the mito-oxidative damage and tumor necrosis factor-α, interleukin 6 and caspase-3 levels in the hippocampus and cortex compared to sham animals. NAC significantly improved memory retention and attenuated oxidative damage parameters, inflammatory markers in STZ-treated rats.
CONCLUSIONS: The results of the present study strongly indicate the effectiveness of NAC in preventing cognitive impairment as well as mito-oxidative stress and may be considered as a potential agent in the management of cognitive-related disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 24756058     DOI: 10.1515/jbcpp-2013-0150

Source DB:  PubMed          Journal:  J Basic Clin Physiol Pharmacol        ISSN: 0792-6855


  11 in total

Review 1.  Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.

Authors:  Pradip K Kamat; Anuradha Kalani; Shivika Rai; Santosh Kumar Tota; Ashok Kumar; Abdullah S Ahmad
Journal:  Mol Neurobiol       Date:  2015-08-23       Impact factor: 5.590

2.  Investigation of the therapeutic potential of N-acetyl cysteine and the tools used to define nigrostriatal degeneration in vivo.

Authors:  Negin Nouraei; Lauren Zarger; Justin N Weilnau; Jimin Han; Daniel M Mason; Rehana K Leak
Journal:  Toxicol Appl Pharmacol       Date:  2016-02-12       Impact factor: 4.219

3.  Activation of Brain Indoleamine-2,3-dioxygenase Contributes to Depressive-Like Behavior Induced by an Intracerebroventricular Injection of Streptozotocin in Mice.

Authors:  Leandro Cattelan Souza; Cristiano R Jesse; Marcelo Gomes de Gomes; Lucian Del Fabbro; André Tiago Rossito Goes; Franciele Donato; Silvana Peterini Boeira
Journal:  Neurochem Res       Date:  2017-06-19       Impact factor: 3.996

4.  Rat brain glucose transporter-2, insulin receptor and glial expression are acute targets of intracerebroventricular streptozotocin: risk factors for sporadic Alzheimer's disease?

Authors:  A Knezovic; A Loncar; J Homolak; U Smailovic; J Osmanovic Barilar; L Ganoci; N Bozina; P Riederer; Melita Salkovic-Petrisic
Journal:  J Neural Transm (Vienna)       Date:  2017-05-03       Impact factor: 3.575

5.  Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders.

Authors:  Sonja K Soo; Paige D Rudich; Annika Traa; Namasthée Harris-Gauthier; Hazel J Shields; Jeremy M Van Raamsdonk
Journal:  Mech Ageing Dev       Date:  2020-06-28       Impact factor: 5.432

6.  Quercetin Exhibits α7nAChR/Nrf2/HO-1-Mediated Neuroprotection Against STZ-Induced Mitochondrial Toxicity and Cognitive Impairments in Experimental Rodents.

Authors:  Niraj Kumar Singh; Debapriya Garabadu
Journal:  Neurotox Res       Date:  2021-09-23       Impact factor: 3.911

7.  Chronic N-acetylcysteine treatment alleviates acute lipopolysaccharide-induced working memory deficit through upregulating caveolin-1 and synaptophysin in mice.

Authors:  Xianzhi Shen; Yanyun Sun; Mengwei Wang; Hui Shu; Li-Juan Zhu; Pei-Yun Yan; Jun-Fang Zhang; Xinchun Jin
Journal:  Psychopharmacology (Berl)       Date:  2017-10-23       Impact factor: 4.530

8.  Neuroprotective effect of N-acetylcysteine against cisplatin-induced toxicity in rat brain by modulation of oxidative stress and inflammation.

Authors:  Wessam M Abdel-Wahab; Farouzia I Moussa
Journal:  Drug Des Devel Ther       Date:  2019-04-11       Impact factor: 4.162

9.  N-acetyl cysteine, inulin and the two as a combined therapy ameliorate cognitive decline in testosterone-deprived rats.

Authors:  Titikorn Chunchai; Puntarik Keawtep; Apiwan Arinno; Napatsorn Saiyasit; Dillon Prus; Nattayaporn Apaijai; Wasana Pratchayasakul; Nipon Chattipakorn; Siriporn C Chattipakorn
Journal:  Aging (Albany NY)       Date:  2019-06-03       Impact factor: 5.682

10.  Effect of β-asarone in normal and β-amyloid-induced Alzheimeric rats.

Authors:  Golshid Saki; Akram Eidi; Pejman Mortazavi; Negar Panahi; Akbar Vahdati
Journal:  Arch Med Sci       Date:  2020-04-25       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.